News Releases
- November 12, 2021Annovis Bio Presented at the 14th Clinical Trials on Alzheimer’s Disease Conference
- November 9, 2021Annovis Bio Presents Poster on Mechanism of Action at the 14th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
- November 2, 2021Annovis Bio to Present at the 14th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
- May 4, 2022Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update
- April 28, 2022Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging
- April 11, 2022Annovis Bio to Participate in World Parkinson's Day to Raise Awareness on the Debilitating Disease
Media Coverage
- May 19, 2022TechNation Radio Podcast: Episode 22-21 What’s Up with Netflix? on Apple Podcasts
- March 11, 2022Biotech IQ Podcast: Is axonal transport the key to solving neurodegenerative diseases? Maria Maccechini, PhD - CEO, Annovis Bio
- February 24, 2022Alzhemier's Speaks Radio: Annovis, a Biotech Company, Shares Updates on Their Research
Events & Presentations
Filings
Filings
Description
Date Filed
Available Formats
25
Notification filed by a National Securities Exchange to Report the Removal from listing and registration of matured , redeemed or retired securities
Nov 26, 2021
E-mail Alerts
Back to Top